Six months of retrospective glycemic control and anthropometric outcomes in type 2 diabetic patients with new dapagliflozin treatment actual clinical experience data from single center.


CANDER S. , ÇALAPKULU M., ÖZ GÜL Ö. , ERSOY C.

20th European Congress of Endocrinology. Barcelona, Spain., 19 - 22 May 2018